NIKTIMVO
Active substance: axatilimab
INJECTION · AXATILIMAB 22 mg/2.2mL
United StatesActive
Marketing holder: Incyte Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- AXATILIMAB · 22 mg/2.2mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-bb43-7cce-949a-c0deb21b906b,01a12091-bb48-7b2a-be2c-8315dd37cdce,01a12093-9a1c-7e37-9ec3-c078f9c91c7d,01a12093-9a25-7cf9-b90b-a0dfb584724e;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50881-047
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 50881-047 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50881-047 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50881-047 · Verified 2026-10-09 · open in source